학술논문

Who should be treated with 'Proactive treatment' for atopic dermatitis? / 「プロアクティブ療法」を日常診療にどのように取り入れていくか?
Document Type
Journal Article
Source
日本小児アレルギー学会誌 / Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology. 2016, 30(1):91
Subject
atopic dermatitis
proactive treatment
tacrolimus ointment
topical corticosteroid
アトピー性皮膚炎
ステロイド外用薬
タクロリムス軟膏
プロアクティブ療法
Language
Japanese
ISSN
0914-2649
1882-2738
Abstract
Proactive treatment for atopic dermatitis may prevent recurrent disease exacerbations in the maintenance treatment phase. Many Japanese paediatricians are already aware of proactive treatment and have applied it to their patients. We review 6 randomised controlled trials of proactive treatment for paediatric patients with atopic dermatitis. Four trials used 16 to 20 weeks of treatment with topical corticosteroids, and two used 40 to 52 weeks of treatment with tacrolimus ointment. Each trial showed proactive treatment to be effective. Side effects did not significantly increase in the proactive intervention group with proactive treatment compared to placebo. Proactive treatment is a good option even for paediatric atopic dermatitis. It is not yet clear whether it is better to treat with topical corticosteroid or tacrolimus ointment and how safe it is to use proactive treatment for long periods.

Online Access